StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
6
Publishing Date
2024 - 01 - 22
7
2023 - 09 - 27
7
2023 - 08 - 15
6
2023 - 06 - 29
6
2023 - 06 - 21
6
2023 - 06 - 20
8
2023 - 05 - 30
6
2023 - 05 - 22
6
2023 - 04 - 17
6
2023 - 03 - 22
6
2023 - 03 - 15
6
2023 - 02 - 13
6
2023 - 02 - 08
6
2022 - 12 - 19
6
2022 - 07 - 19
6
2022 - 06 - 21
8
2022 - 05 - 03
6
2022 - 04 - 13
6
2022 - 04 - 06
7
2022 - 04 - 05
6
2022 - 03 - 16
6
2022 - 03 - 01
8
2022 - 02 - 23
7
2022 - 02 - 10
7
2022 - 01 - 31
7
2021 - 12 - 21
7
2021 - 12 - 15
8
2021 - 12 - 07
6
2021 - 10 - 12
7
2021 - 09 - 29
6
2021 - 09 - 28
6
2021 - 09 - 20
6
2021 - 09 - 08
6
2021 - 08 - 23
7
2021 - 08 - 10
6
2021 - 08 - 02
8
2021 - 07 - 20
6
2021 - 07 - 19
6
2021 - 06 - 29
7
2021 - 06 - 25
6
2021 - 06 - 16
6
2021 - 06 - 11
13
2021 - 06 - 10
9
2021 - 06 - 07
6
2021 - 05 - 28
11
2021 - 05 - 26
6
2021 - 05 - 25
6
2021 - 05 - 21
10
2021 - 05 - 20
6
2021 - 05 - 12
6
2021 - 05 - 04
11
2021 - 05 - 03
7
2021 - 04 - 23
7
2021 - 04 - 22
6
2021 - 04 - 01
6
2021 - 03 - 22
6
2021 - 03 - 08
6
2021 - 01 - 28
7
2020 - 12 - 21
10
2020 - 12 - 17
10
Sector
Health technology
5
Manufacturing
1
Tags
5g
3
Acquisition
10
Alliances
4
Application
3
Approval
6
Automotive
3
Awards
6
Battery
3
Biocanada
4
Biocapital
3
Biomidwest
7
Biotech
3
Biotech-beach
3
Biotechnology
3
Cancer
5
Clinical-trials-phase-ii
7
Clinical-trials-phase-iii
4
Collaboration
5
Communications
3
Conference
28
Corporation
13
Day
4
Deadline
18
Deal
3
Designation
7
Disease
6
Distribution
3
Drug
3
Earnings
16
Energy
13
Events
7
Fda
6
Group
14
Growth
21
Health
8
Innovation
6
International
4
Management
4
Market
37
N/a
371
Offering
5
Partnership
5
Pharma
4
Phase 3
4
Platform
8
Pre-clinical
5
Preclinical
5
Program
10
Report
26
Research
6
Results
91
Service
6
Services
7
Solutions
7
System
7
Technology
7
Therapeutics
23
Therapy
9
Treatment
12
Trial
10
Entities
Allied corp.
1
Bristol-myers squibb company
1
Exelixis, inc.
1
Jaguar health, inc.
1
Phathom pharmaceuticals, inc.
1
Smith & nephew plc
1
Sonoma pharmaceuticals, inc.
1
Stryker corporation
1
Takeda pharmaceutical company limited
1
Symbols
ALID
1
BMY
1
EXEL
1
JAGX
1
PHAT
1
SNNUF
1
SNOA
1
SYK
1
TAK
1
Exchanges
Nasdaq
6
Nyse
2
Crawled Date
2022 - 05 - 07
1
2022 - 05 - 03
5
Crawled Time
11:00
1
12:00
1
13:00
1
16:20
1
18:00
1
22:00
1
Source
jaguarhealth.gcs-web.com
1
www.biospace.com
2
www.globenewswire.com
2
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2022 - 05 - 03
tags :
Approval
save search
Jaguar Health Completes Final Regulatory Filing for Conditional New Animal Drug Approval of Canalevia (Crofelemer) to Treat Exercise-induced Diarrhea (EID) in Dogs
Published:
2022-05-03
(Crawled : 16:20)
- jaguarhealth.gcs-web.com
JAGX
|
$0.158
-10.79%
-12.09%
30M
|
Health Technology
|
-64.46%
|
O:
2.18%
H:
2.17%
C:
-0.41%
drug
diarrhea
health
approval
Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA™ TRIPLE PAK™ (vonoprazan, amoxicillin, clarithromycin) and VOQUEZNA™ DUAL PAK™ (vonoprazan, amoxicillin) for the Treatment of H. pylori Infection in Adults
Published:
2022-05-03
(Crawled : 22:00)
- globenewswire.com
PHAT
|
$8.98
-5.27%
-5.57%
590K
|
Health Technology
|
-38.69%
|
O:
-3.35%
H:
0.0%
C:
-3.47%
treatment
fda
approval
infection
infections
Exelixis’ Partner Ipsen Receives European Commission Approval for CABOMETYX® (cabozantinib) for Patients with Previously Treated Radioactive Iodine-Refractory Differentiated Thyroid Cancer
Published:
2022-05-03
(Crawled : 18:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-8.63%
|
O:
0.41%
H:
0.0%
C:
0.0%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-34.83%
|
O:
0.36%
H:
0.0%
C:
0.0%
EXEL
|
$22.51
0.09%
0.09%
2.3M
|
Health Technology
|
-0.62%
|
O:
0.09%
H:
1.54%
C:
-0.44%
cabometyx
approval
cancer
Allied Corp Announces Approval of Psychoactive (THC) Quota for the Production of Colombian THC Cannabis Flower
Published:
2022-05-03
(Crawled : 13:00)
- globenewswire.com
ALID
|
$0.1616
-73.85%
11K
|
Manufacturing
|
-77.82%
|
O:
-0.14%
H:
6.8%
C:
5.41%
cannabis
thc
approval
Global Amniotic Membrane Markets, 2022-2027: Increasing Awareness About Amniotic Membranes (AM) Due to Gaining Approval of Many Health Commissions
Published:
2022-05-03
(Crawled : 12:00)
- prnewswire.com
SYK
|
$325.43
-0.62%
0.0%
1.8M
|
Health Technology
|
34.14%
|
O:
-2.04%
H:
0.0%
C:
0.0%
health
approval
Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce EPA Approval for Nanocyn® Hospital-Grade Disinfectant in the U.S.
Published:
2022-05-03
(Crawled : 11:00)
- biospace.com/
SNOA
|
$0.1539
-1.72%
-1.75%
170K
|
Health Technology
|
-94.36%
|
O:
49.22%
H:
3.27%
C:
-11.84%
nanocyn
approval
disinfectant
group
Gainers vs Losers
67%
33%
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.